|
US8288557B2
(en)
|
2004-07-23 |
2012-10-16 |
Endocyte, Inc. |
Bivalent linkers and conjugates thereof
|
|
CN101678124A
(zh)
|
2007-03-14 |
2010-03-24 |
恩多塞特公司 |
结合配体连接的微管溶素递药缀合物
|
|
US9877965B2
(en)
|
2007-06-25 |
2018-01-30 |
Endocyte, Inc. |
Vitamin receptor drug delivery conjugates for treating inflammation
|
|
CN101784565B
(zh)
|
2007-06-25 |
2014-12-10 |
恩多塞特公司 |
含有亲水性间隔区接头的共轭物
|
|
WO2013126797A1
(en)
|
2012-02-24 |
2013-08-29 |
Purdue Research Foundation |
Cholecystokinin b receptor targeting for imaging and therapy
|
|
US20140080175A1
(en)
|
2012-03-29 |
2014-03-20 |
Endocyte, Inc. |
Processes for preparing tubulysin derivatives and conjugates thereof
|
|
US20140079636A1
(en)
|
2012-04-16 |
2014-03-20 |
Dinesh U. Chimmanamada |
Targeted therapeutics
|
|
HK1208216A1
(en)
|
2012-05-15 |
2016-02-26 |
Concortis Biosystems, Corp |
Drug-conjugates, conjugation methods, and uses thereof
|
|
AU2013331440A1
(en)
|
2012-10-16 |
2015-04-30 |
Endocyte, Inc. |
Drug delivery conjugates containing unnatural amino acids and methods for using
|
|
AR094280A1
(es)
|
2012-12-21 |
2015-07-22 |
Bioalliance Cv |
Enlazantes hidrofilicos auto-inmolantes y conjugados de los mismos
|
|
AU2014228489B2
(en)
|
2013-03-15 |
2018-11-15 |
Zymeworks Bc Inc. |
Cytotoxic and anti-mitotic compounds, and methods of using the same
|
|
US10017460B2
(en)
|
2013-06-12 |
2018-07-10 |
Organolinx Corp. |
Compounds for promoting liposomal and cellular adhesion and compositions and methods of use thereof
|
|
WO2015038649A1
(en)
|
2013-09-10 |
2015-03-19 |
Synta Pharmaceuticals Corp. |
Targeted therapeutics
|
|
CA3187392A1
(en)
|
2013-10-15 |
2015-04-23 |
Seagen Inc. |
Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics
|
|
AU2014337317A1
(en)
|
2013-10-15 |
2016-09-15 |
Sorrento Therapeutics Inc. |
Drug-conjugates with a targeting molecule and two different drugs
|
|
WO2015066053A2
(en)
|
2013-10-28 |
2015-05-07 |
Synta Pharmaceuticals Corp. |
Targeted therapeutics
|
|
DK3086815T3
(da)
|
2013-12-27 |
2022-05-23 |
Zymeworks Inc |
Sulfonamidholdige forbindelsessystemer til lægemiddelkonjugater
|
|
KR20160125361A
(ko)
*
|
2013-12-27 |
2016-10-31 |
자임워크스 인코포레이티드 |
Ｖａｒ２ｃｓａ－약물 접합체
|
|
CN106132959B
(zh)
*
|
2014-01-28 |
2020-04-17 |
管道制药有限责任公司 |
用于缀合的细胞毒性微管溶素化合物
|
|
EP3099332A4
(en)
|
2014-01-29 |
2017-06-21 |
Madrigal Pharmaceuticals, Inc. |
Targeted therapeutics
|
|
GB201402006D0
(en)
|
2014-02-06 |
2014-03-26 |
Oncomatryx Biopharma S L |
Antibody-drug conjugates and immunotoxins
|
|
JP6576942B6
(ja)
|
2014-03-03 |
2019-11-27 |
マドリガル ファーマシューティカルズ インコーポレイテッド |
標的治療薬
|
|
WO2015143004A1
(en)
|
2014-03-18 |
2015-09-24 |
Synta Pharmaceuticals Corp. |
Targeted therapeutics
|
|
JP2017519740A
(ja)
|
2014-05-28 |
2017-07-20 |
アジェンシス，インコーポレイテッド |
ドラプロイン‐ドライソロイインペプチド誘導体
|
|
MX2016016490A
(es)
|
2014-06-20 |
2017-07-28 |
Bioalliance Cv |
Conjugados de farmaco-anticuerpo anti-receptor de folato alfa (fra) y metodos de uso de los mismos.
|
|
IL296633A
(en)
|
2014-07-11 |
2022-11-01 |
Genmab As |
Antibodies that bind axl
|
|
DK3191502T3
(da)
*
|
2014-09-11 |
2021-07-19 |
Seagen Inc |
Målrettet indgivelse af tertiært aminholdige lægemiddelstoffer
|
|
RU2723651C2
(ru)
*
|
2014-09-17 |
2020-06-17 |
Займворкс Инк. |
Цитотоксические и антимитотические соединения и способы их применения
|
|
EP3218009B1
(en)
|
2014-10-14 |
2021-04-07 |
Polytherics Limited |
Process for the conjugation of a peptide or protein with a reagent comprising a leaving group including a portion of peg
|
|
US10077287B2
(en)
|
2014-11-10 |
2018-09-18 |
Bristol-Myers Squibb Company |
Tubulysin analogs and methods of making and use
|
|
EA201791203A1
(ru)
*
|
2014-12-08 |
2018-04-30 |
Сорренто Терапьютикс, Инк. |
ЛЕКАРСТВЕННЫЙ КОНЪЮГАТ АНТИТЕЛА ПРОТИВ с-МЕТ
|
|
US9968683B2
(en)
|
2014-12-17 |
2018-05-15 |
Organolinx Corp. |
Method for conjugating molecules
|
|
WO2016123412A1
(en)
*
|
2015-01-28 |
2016-08-04 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates
|
|
JP2018507844A
(ja)
*
|
2015-02-06 |
2018-03-22 |
ソレント・セラピューティクス・インコーポレイテッドＳｏｒｒｅｎｔｏ Ｔｈｅｒａｐｅｕｔｉｃｓ， Ｉｎｃ． |
抗体薬物コンジュゲート
|
|
KR20170117473A
(ko)
*
|
2015-02-15 |
2017-10-23 |
지앙수 헨그루이 메디슨 컴퍼니 리미티드 |
리간드-세포독성 약물 접합체, 이의 제조 방법 및 이의 적용
|
|
CN106279352B
(zh)
|
2015-05-29 |
2020-05-22 |
上海新理念生物医药科技有限公司 |
海兔毒素10的衍生物及其应用
|
|
JP6802840B2
(ja)
|
2015-06-09 |
2020-12-23 |
エックスディーシーエクスプローラー （シャンハイ） カンパニー リミテッド |
抗体薬物複合体、中間体、その製造方法、薬学的組成物及び応用
|
|
CA2991805A1
(en)
|
2015-07-10 |
2017-01-19 |
Genmab A/S |
Axl-specific antibody-drug conjugates for cancer treatment
|
|
NZ739830A
(en)
|
2015-07-12 |
2021-12-24 |
Hangzhou Dac Biotech Co Ltd |
Bridge linkers for conjugation of cell-binding molecules
|
|
US9839687B2
(en)
|
2015-07-15 |
2017-12-12 |
Suzhou M-Conj Biotech Co., Ltd. |
Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule
|
|
WO2017054080A1
(en)
*
|
2015-09-29 |
2017-04-06 |
Zymeworks Inc. |
Cytotoxic and anti-mitotic compounds, and methods of using the same
|
|
WO2017058808A1
(en)
*
|
2015-10-02 |
2017-04-06 |
Sirenas Llc |
Anti-cancer compounds and conjugates thereof
|
|
EP3165532B1
(en)
|
2015-11-03 |
2018-12-19 |
Industrial Technology Research Institute |
Auristatin derivatives, linker-drugs and ligand-drug conjugates
|
|
CN106729743B
(zh)
*
|
2015-11-23 |
2021-09-21 |
四川科伦博泰生物医药股份有限公司 |
抗ErbB2抗体-药物偶联物及其组合物、制备方法和应用
|
|
US11229708B2
(en)
|
2015-12-04 |
2022-01-25 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
US11793880B2
(en)
|
2015-12-04 |
2023-10-24 |
Seagen Inc. |
Conjugates of quaternized tubulysin compounds
|
|
RU2766000C2
(ru)
|
2016-01-08 |
2022-02-07 |
АльтруБио Инк. |
Четырехвалентные антитела к psgl-1 и их применения
|
|
CN107029244B
(zh)
*
|
2016-02-04 |
2021-04-27 |
浙江昭华生物医药有限公司 |
抗her2抗体-药物偶联物及其应用
|
|
JOP20170053B1
(ar)
|
2016-03-02 |
2021-08-17 |
Eisai Randd Man Co Ltd |
مترافقات جسم مضاد وعقار أساسها إيريبولين وطرق استخدامها
|
|
MA43835A
(fr)
|
2016-03-25 |
2018-11-28 |
Seattle Genetics Inc |
Procédé de préparation de lieurs de médicaments pégylés et leurs intermédiaires
|
|
BR112018016008A2
(pt)
|
2016-03-29 |
2018-12-18 |
Toray Industries, Inc. |
derivado de peptídeo ou o sal farmaceuticamente aceitável do mesmo, conjugado ou um sal farmaceuticamente aceitável do mesmo, e, agente citotóxico.
|
|
US20170281758A1
(en)
*
|
2016-03-29 |
2017-10-05 |
Sorrento Therapeutics, Inc. |
Calicheamicin antibody drug conjugates linking an amidoacetyl group to a sugar moiety on calicheamicin
|
|
KR102775461B1
(ko)
|
2016-04-01 |
2025-02-28 |
어비디티 바이오사이언시스 인크. |
핵산-폴리펩타이드 조성물 및 이의 용도
|
|
CA3025931A1
(en)
*
|
2016-05-31 |
2017-12-07 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates having derivatives of amatoxin as the drug
|
|
KR20230066647A
(ko)
|
2016-06-17 |
2023-05-16 |
마젠타 테라퓨틱스 인코포레이티드 |
Cd117+ 세포의 고갈을 위한 조성물 및 방법
|
|
WO2018036438A1
(zh)
*
|
2016-08-23 |
2018-03-01 |
四川科伦博泰生物医药股份有限公司 |
一种抗体-药物偶联物及其制备方法和应用
|
|
US10517958B2
(en)
|
2016-10-04 |
2019-12-31 |
Zymeworks Inc. |
Compositions and methods for the treatment of platinum-drug resistant cancer
|
|
CN108101825B
(zh)
*
|
2016-11-25 |
2022-02-22 |
迈威(上海)生物科技股份有限公司 |
用于抗体-药物偶联的双取代马来酰胺类连接子及其制备方法和用途
|
|
PL3546448T3
(pl)
*
|
2016-11-25 |
2022-09-05 |
Mabwell (shanghai) Bioscience Co., Ltd. |
Łącznik stanowiący dipodstawiony amid kwasu maleinowego dla koniugacji przeciwciało-lek oraz sposób jego wytwarzania i zastosowanie
|
|
CN109810039B
(zh)
*
|
2017-11-22 |
2021-11-12 |
迈威(上海)生物科技股份有限公司 |
一种用于抗体-药物偶联的双取代马来酰胺类连接子及其制备方法和用途
|
|
US10864279B2
(en)
|
2016-12-16 |
2020-12-15 |
Industrial Technology Research Institute |
Linker-drug and antibody-drug conjugate (ADC) employing the same
|
|
SG10202107429WA
(en)
|
2017-01-06 |
2021-08-30 |
Avidity Biosciences Inc |
Nucleic acid-polypeptide compositions and methods of inducing exon skipping
|
|
WO2018134787A2
(en)
|
2017-01-20 |
2018-07-26 |
Magenta Therapeutics, Inc. |
Compositions and methods for the depletion of cd137+ cells
|
|
KR102648564B1
(ko)
|
2017-03-24 |
2024-03-19 |
씨젠 인크. |
글루쿠로니드 약물-링커의 제조 공정 및 그 중간물
|
|
EP3606922A4
(en)
*
|
2017-04-06 |
2021-03-03 |
Hangzhou Dac Biotech Co., Ltd |
CONJUGATION OF A CYTOSTATIC WITH BIS CONNECTION
|
|
EP3617221A4
(en)
|
2017-04-19 |
2021-04-14 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
CYTOTOXIN AND CONJUGATE, USES THEREOF AND MANUFACTURING PROCESSES THEREFORE
|
|
CA3067311A1
(en)
*
|
2017-06-20 |
2018-12-27 |
Sorrento Therapeutics, Inc. |
Cd38 antibody drug conjugate
|
|
KR20200016874A
(ko)
|
2017-06-20 |
2020-02-17 |
마드리갈 파마슈티칼스 인코포레이티드 |
표적화 치료제를 포함하는 병용 요법
|
|
US11377447B2
(en)
|
2017-06-20 |
2022-07-05 |
Madrigal Pharmaceuticals, Inc. |
Targeted therapeutics
|
|
GB201711809D0
(en)
|
2017-07-21 |
2017-09-06 |
Governors Of The Univ Of Alberta |
Antisense oligonucleotide
|
|
JP7368856B2
(ja)
|
2017-07-25 |
2023-10-25 |
トゥルーバインディング，インコーポレイテッド |
Ｔｉｍ－３とそのリガンドとの相互作用の遮断によるがん治療
|
|
US10799598B2
(en)
|
2017-08-01 |
2020-10-13 |
Sorrento Therapeutics, Inc. |
Disulfide bridging conjugates
|
|
JP7202301B2
(ja)
|
2017-08-10 |
2023-01-11 |
住友ファーマ株式会社 |
ヘミアスタリン誘導体及びこれらの抗体薬物複合体
|
|
CN111601803A
(zh)
|
2017-09-08 |
2020-08-28 |
西雅图基因公司 |
微管溶素及其中间体的制备方法
|
|
CN111655268B
(zh)
|
2017-10-04 |
2024-03-26 |
艾维迪提生物科学公司 |
核酸-多肽组合物及其用途
|
|
CN111417408B
(zh)
|
2017-11-30 |
2024-04-23 |
思进公司 |
药物接头化合物的制备方法
|
|
CN118638787A
(zh)
|
2017-12-06 |
2024-09-13 |
艾维迪提生物科学公司 |
治疗肌萎缩和强直性肌营养不良的组合物和方法
|
|
EP4667495A3
(en)
|
2017-12-15 |
2026-03-11 |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. |
Bioactive molecule conjugate, preparation method and use thereof
|
|
WO2019149116A1
(zh)
*
|
2018-01-30 |
2019-08-08 |
四川科伦博泰生物医药股份有限公司 |
制备偶联物的方法
|
|
IL276546B2
(en)
*
|
2018-02-20 |
2024-08-01 |
Seagen Inc |
Hydrophobic auristatin F compounds and their conjugates
|
|
WO2019232449A1
(en)
|
2018-06-01 |
2019-12-05 |
Eisai R&D Management Co., Ltd. |
Splicing modulator antibody-drug conjugates and methods of use
|
|
JP7346466B2
(ja)
|
2018-06-01 |
2023-09-19 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
スプライシング調節薬の使用方法
|
|
US20210276971A1
(en)
|
2018-06-20 |
2021-09-09 |
The Research Foundation For The State University Of New York |
Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same
|
|
CN113195487A
(zh)
*
|
2018-10-12 |
2021-07-30 |
杭州多禧生物科技有限公司 |
2，3-二氨基琥珀酰基偶联物连接子
|
|
WO2020081493A1
(en)
|
2018-10-16 |
2020-04-23 |
Molecular Templates, Inc. |
Pd-l1 binding proteins
|
|
BR112021010936A2
(pt)
|
2018-12-13 |
2021-08-31 |
Eisai R&D Management Co., Ltd. |
Conjugados anticorpo-fármaco de herboxidieno e métodos de uso
|
|
IL319265A
(en)
|
2018-12-21 |
2025-04-01 |
Avidity Biosciences Inc |
Anti-transferrin receptor antibodies and their uses
|
|
EP3897734A4
(en)
*
|
2018-12-21 |
2022-12-07 |
Seagen Inc. |
ADC COMPRISING MULTIPLEX THIOL LINKERS
|
|
CN120058944A
(zh)
|
2019-01-30 |
2025-05-30 |
真和制药有限公司 |
抗gal3抗体及其用途
|
|
US12178879B2
(en)
|
2019-02-13 |
2024-12-31 |
Sumitomo Pharma Co., Ltd. |
Hemiasterlin derivative and antibody-drug conjugate thereof
|
|
WO2020166600A1
(ja)
|
2019-02-13 |
2020-08-20 |
大日本住友製薬株式会社 |
システイン残基を有するヘミアスタリン誘導体
|
|
CN109824759A
(zh)
*
|
2019-03-08 |
2019-05-31 |
联宁（苏州）生物制药有限公司 |
一种用于抗体药物偶联物的药物-连接子mc-mmaf的制备方法及其中间体
|
|
EP3959319A4
(en)
|
2019-04-25 |
2023-06-07 |
Avidity Biosciences, Inc. |
NUCLEIC ACID COMPOSITIONS AND METHODS FOR MULTI-EXON SKIPPING
|
|
US11578090B2
(en)
|
2019-06-06 |
2023-02-14 |
Avidity Biosciences, Inc. |
Nucleic acid-polypeptide compositions and uses thereof
|
|
JP7581252B2
(ja)
|
2019-06-06 |
2024-11-12 |
アビディティー バイオサイエンシーズ，インク． |
Ｕｎａアミダイトおよびその使用
|
|
US11918649B2
(en)
|
2019-09-18 |
2024-03-05 |
Molecular Templates, Inc. |
PD-L1-binding molecules comprising Shiga toxin a subunit scaffolds
|
|
CA3164060A1
(en)
|
2019-12-06 |
2021-06-10 |
Truebinding, Inc. |
Antibodies that disrupt the interaction of gal3 and insulin receptor or integrins and methods of use thereof
|
|
CN115666656A
(zh)
|
2020-01-13 |
2023-01-31 |
西纳福克斯股份有限公司 |
通过环加成双侧功能化抗体
|
|
JP7807375B2
(ja)
|
2020-01-13 |
2026-01-27 |
シンアフィックス ビー．ブイ． |
付加環化を介して両側官能化された抗体
|
|
EP4090377A1
(en)
|
2020-01-13 |
2022-11-23 |
Synaffix B.V. |
Conjugates of antibodies an immune cell engagers
|
|
WO2021173612A1
(en)
|
2020-02-26 |
2021-09-02 |
Sorrento Therapeutics, Inc. |
Activatable antigen binding proteins with universal masking moieties
|
|
FR3107648B1
(fr)
*
|
2020-02-27 |
2022-03-18 |
Mc Saf |
conjugués anticorps-médicament anti-CD56 et leur utilisation en thérapie
|
|
CA3170633A1
(en)
*
|
2020-03-09 |
2021-09-16 |
David Goeddel |
Efficient preparation of dolastatin and auristatin analogs through a common intermediate
|
|
AU2021237465A1
(en)
|
2020-03-19 |
2022-10-13 |
Avidity Biosciences, Inc. |
Compositions and methods of treating Facioscapulohumeral muscular dystrophy
|
|
IL296393B1
(en)
|
2020-03-27 |
2025-12-01 |
Avidity Biosciences Inc |
Compositions and methods of treating muscle dystrophy
|
|
US10987487B1
(en)
|
2020-04-29 |
2021-04-27 |
Cure Medical Llc |
Gripper sleeve for urinary catheter
|
|
JP2023528797A
(ja)
|
2020-05-26 |
2023-07-06 |
トゥルーバインディング，インコーポレイテッド |
ガレクチン－３を遮断することにより炎症性疾患を処置する方法
|
|
TWI901692B
(zh)
|
2020-06-05 |
2025-10-21 |
日商衛材R&D企管股份有限公司 |
抗ｂｃｍａ抗體-藥物軛合物及其使用方法
|
|
EP4172141A1
(en)
|
2020-06-26 |
2023-05-03 |
Synaffix B.V. |
Methods for the preparation of linker payload constructs
|
|
NL2026400B1
(en)
|
2020-09-02 |
2022-05-04 |
Synaffix Bv |
Methods for the preparation of bioconjugates
|
|
EP4208259A2
(en)
|
2020-09-04 |
2023-07-12 |
NovaRock Biotherapeutics, Ltd. |
Nectin-4 antibodies and uses thereof
|
|
EP4213885A1
(en)
|
2020-09-15 |
2023-07-26 |
Synaffix B.V. |
Antibody-exatecan conjugates
|
|
NL2026947B1
(en)
|
2020-11-20 |
2022-07-01 |
Synaffix Bv |
Tyrosine-based antibody conjugates
|
|
WO2022136555A1
(en)
|
2020-12-23 |
2022-06-30 |
Ludwig-Maximilians-Universitaet Muenchen |
Improved cd30 targeting antibody drug conjugates and uses thereof
|
|
US20230390411A1
(en)
*
|
2021-01-28 |
2023-12-07 |
Nanjing Chempion Biotechnology Co., Ltd. |
Conjugate and use thereof
|
|
JP2024506022A
(ja)
|
2021-02-08 |
2024-02-08 |
シンアフィックス ビー．ブイ． |
多機能性抗体
|
|
CN117440832A
(zh)
|
2021-03-03 |
2024-01-23 |
索伦托药业有限公司 |
包括抗bcma抗体的抗体-药物缀合物
|
|
EP4308242A1
(en)
|
2021-03-17 |
2024-01-24 |
Molecular Templates, Inc. |
Pd-l1 binding proteins comprising shiga toxin a subunit scaffolds and cd8+ t cell antigens
|
|
CN116897149A
(zh)
*
|
2021-03-30 |
2023-10-17 |
上海复旦张江生物医药股份有限公司 |
一种连接基药物偶联物的制备方法及其中间体
|
|
US20250026838A1
(en)
|
2021-07-13 |
2025-01-23 |
Truebinding, Inc. |
Methods of preventing protein aggregation
|
|
CN118265544A
(zh)
|
2021-09-16 |
2024-06-28 |
艾维迪提生物科学公司 |
治疗面肩肱型肌营养不良的组合物和方法
|
|
CN118524852A
(zh)
|
2021-11-09 |
2024-08-20 |
真和制药有限公司 |
治疗或抑制心血管疾病的方法
|
|
CN118660722A
(zh)
|
2021-12-23 |
2024-09-17 |
米雷楚来有限公司 |
用于递送多核苷酸的组合物
|
|
US20250205350A1
(en)
|
2022-03-10 |
2025-06-26 |
Vivasor, Inc. |
Antibody-Drug Conjugates and Uses Thereof
|
|
US12071621B2
(en)
|
2022-04-05 |
2024-08-27 |
Avidity Biosciences, Inc. |
Anti-transferrin receptor antibody-PMO conjugates for inducing DMD exon 44 skipping
|
|
AU2023314808A1
(en)
|
2022-07-29 |
2025-03-20 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for transferrin receptor (tfr)-mediated delivery to the brain and muscle
|
|
WO2024038065A1
(en)
|
2022-08-15 |
2024-02-22 |
Synaffix B.V. |
Anthracyclins and conjugates thereof
|
|
WO2024067841A1
(zh)
|
2022-09-30 |
2024-04-04 |
上海迪诺医药科技有限公司 |
苯并氮杂卓衍生物、含其的偶联物及其应用
|
|
WO2024107765A2
(en)
|
2022-11-14 |
2024-05-23 |
Regeneron Pharmaceuticals, Inc. |
Compositions and methods for fibroblast growth factor receptor 3-mediated delivery to astrocytes
|
|
EP4389152A1
(en)
|
2022-12-23 |
2024-06-26 |
Synaffix B.V. |
Conjugates of pbd prodrugs
|
|
CN116621927B
(zh)
*
|
2023-01-09 |
2024-03-26 |
联宁（苏州）生物制药有限公司 |
带有伊喜替康和C-lock定点偶联基团的抗体偶联中间体、偶联方法及抗体偶联药物
|
|
EP4410313A1
(en)
|
2023-01-31 |
2024-08-07 |
Synaffix B.V. |
Homogeneous antibody-conjugates with high payload loading
|
|
JP2026506849A
(ja)
|
2023-02-28 |
2026-02-27 |
スーチュアン・コールン－バイオテック・バイオファーマシューティカル・カンパニー・リミテッド |
化学結合リンカー及びその用途
|
|
EP4687997A2
(en)
|
2023-04-05 |
2026-02-11 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
WO2024211235A1
(en)
|
2023-04-05 |
2024-10-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
WO2024211234A1
(en)
|
2023-04-05 |
2024-10-10 |
Sorrento Therapeutics, Inc. |
Antibody-drug conjugates and uses thereof
|
|
CN121219014A
(zh)
|
2023-04-17 |
2025-12-26 |
西纳福克斯股份有限公司 |
可切割的免疫细胞接合器
|
|
EP4450093A1
(en)
|
2023-04-17 |
2024-10-23 |
Synaffix B.V. |
Cleavable immune cell engagers
|
|
WO2025006639A2
(en)
|
2023-06-27 |
2025-01-02 |
Avidity Biosciences, Inc. |
Compositions and methods of using prkag2-targeting antibody-oligonucleotide conjugates abstract
|
|
US12409230B2
(en)
|
2023-06-30 |
2025-09-09 |
Avidity Biosciences, Inc. |
Compositions comprising PLN-targeting anti-transferrin receptor antibody-polynucleotides and methods of use thereof to treat cardiomyopathy
|
|
WO2025027529A1
(en)
|
2023-07-31 |
2025-02-06 |
Advesya |
Anti-il-1rap antibody drug conjugates and methods of use thereof
|
|
WO2025126157A1
(en)
|
2023-12-15 |
2025-06-19 |
Advesya |
Anti-il-1rap binding domains and antibody-drug conjugates thereof
|
|
CN117964682A
(zh)
*
|
2024-01-12 |
2024-05-03 |
杭州爱科瑞思生物医药有限公司 |
Dolastatin衍生物及其制备方法和应用
|
|
WO2025238253A1
(en)
|
2024-05-16 |
2025-11-20 |
Synaffix B.V. |
Antibody-oligonucleotide conjugates
|
|
WO2026008881A1
(en)
|
2024-07-05 |
2026-01-08 |
Synaffix B.V. |
Extracellular vesicles comprising biomolecule-conjugates
|
|
WO2026020031A2
(en)
|
2024-07-18 |
2026-01-22 |
Novarock Biotherapeutics, Ltd. |
Cdh17 antibodies and uses thereof
|